July 5 (Reuters) - U.S. private equity firm Carlyle Group is in exclusive talks to acquire medical device maker Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, the Wall Street Journal reported on Friday.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)